Call for Addressing Patient Trajectories in Rheumatic and Musculoskeletal Diseases (Belgium)

The King Baudouin Foundation has launched a research funding opportunity to support collaborative studies on patient trajectories in rheumatic and musculoskeletal diseases (RMDs) within the Belgian healthcare system. The programme aims to improve understanding of diagnosis pathways, treatment journeys, healthcare delivery, and patient outcomes through evidence-based research.

The grant provides up to €150,000 for eligible research projects led by certified rheumatologists affiliated with Belgian academic or clinical institutions.

About the Collaborative Research on RMD Patient Trajectories Grant

The King Baudouin Foundation is inviting applications for collaborative research projects focused on rheumatic and musculoskeletal diseases (RMDs) and the experiences of patients throughout the Belgian healthcare system.

The funding opportunity is launched as part of the centennial anniversary of the Royal Belgian Society of Rheumatology and aims to strengthen knowledge about how patients move through healthcare pathways, from the first signs of disease to diagnosis, treatment, and long-term care.

The programme supports research that can contribute to:

Improved patient care.
Better healthcare planning.
More efficient referral and treatment pathways.
Evidence-based health policy development.
Improved management of rheumatic and musculoskeletal diseases.

Research Focus Areas

The grant supports research examining patient trajectories in RMDs, including the factors that influence healthcare experiences and outcomes.

Eligible research topics may explore:

Clinical Factors

Studies may investigate:

Disease progression.
Symptoms and early disease indicators.
Diagnosis processes.
Treatment responses.
Long-term health outcomes.

Epidemiological Factors

Research may examine:

Disease prevalence.
Patient populations.
Healthcare access patterns.
Regional differences in care delivery.

Healthcare System Pathways

Projects may focus on:

First healthcare contact.
Referral pathways.
Time to diagnosis.
Specialist consultations.
Treatment coordination.
Long-term follow-up.

Biological Determinants

Research may include:

Disease mechanisms.
Biological markers.
Factors influencing disease progression.
Patient-specific treatment approaches.

What Are Rheumatic and Musculoskeletal Diseases (RMDs)?

Rheumatic and musculoskeletal diseases are a broad group of conditions affecting:

Joints.
Muscles.
Bones.
Connective tissues.
The immune system.

These conditions can cause chronic pain, disability, reduced mobility, and increased healthcare needs.

In Belgium, RMDs represent a significant public health challenge because they contribute to:

Long-term disability.
Reduced quality of life.
Increased healthcare utilization.
Demand for specialized medical services.

Why This Research Matters

Understanding patient trajectories helps identify challenges within healthcare systems and improve how patients receive care.

Research supported through this programme can help answer important questions, such as:

How quickly are patients diagnosed after symptoms appear?
Are referral pathways effective?
Where do delays occur in treatment?
How can healthcare services better support patients with chronic conditions?
What factors influence long-term outcomes?

The findings may support improvements in:

Clinical practice.
Healthcare organization.
Patient support systems.
National health policies.

Funding Information

The King Baudouin Foundation will provide funding of up to:

Maximum Grant Amount: €150,000

The funding is intended to support collaborative research projects focused on patient trajectories in rheumatic and musculoskeletal diseases.

Who Is Eligible?

The main applicant must meet the following requirements:

Be a certified adult or pediatric rheumatologist.
Be affiliated with a Belgian academic or clinical institution.
Demonstrate identifiable research experience.

Participation of Rheumatologists in Training

Rheumatologists who are still in training may participate as members of research teams.

However:

They cannot serve as the main applicant.
They must participate under the supervision of an eligible lead researcher.

How the Research Programme Works

The programme supports collaborative research designed to generate evidence on patient pathways in Belgium.

A typical project may involve:

Defining the Research Question
- Identify key challenges in RMD patient trajectories.
- Establish the objectives of the study.
Collecting and Analysing Data
- Study healthcare pathways.
- Analyse clinical, epidemiological, healthcare, or biological information.
Generating Evidence
- Identify gaps and improvement opportunities.
- Develop recommendations for better healthcare delivery.
Sharing Research Outcomes
- Contribute findings to medical communities.
- Support healthcare improvements and policy discussions.

How to Apply

Eligible applicants should prepare a collaborative research proposal that demonstrates:

The importance of the research question.
The relevance to RMD patient trajectories.
The expertise of the research team.
The expected contribution to healthcare improvement.

Applicants should ensure that their submission includes:

Research objectives.
Study methodology.
Team qualifications.
Institutional affiliation details.
Expected impact of the research.

Tips for a Strong Application

Applicants can improve their proposals by:

Clearly explaining the healthcare challenge being addressed.
Demonstrating how the research improves understanding of patient journeys.
Highlighting collaboration between researchers and healthcare professionals.
Providing a strong methodology.
Connecting research outcomes with practical healthcare improvements.

Common Mistakes to Avoid

Applicants should avoid:

Submitting research unrelated to patient trajectories.
Failing to demonstrate rheumatology expertise.
Providing unclear research objectives.
Not explaining the relevance to the Belgian healthcare system.
Submitting proposals without sufficient institutional support.

Frequently Asked Questions (FAQs)

1. What is the purpose of this King Baudouin Foundation grant?

The grant supports collaborative research on patient trajectories in rheumatic and musculoskeletal diseases to improve healthcare pathways, patient outcomes, and health policy in Belgium.

2. What diseases are included under RMD research?

The programme covers rheumatic and musculoskeletal diseases, including both common and rare conditions affecting joints, muscles, bones, and connective tissues.

3. How much funding is available?

Eligible research projects can receive funding of up to €150,000.

4. Who can apply as the main researcher?

The main applicant must be a certified adult or pediatric rheumatologist affiliated with a Belgian academic or clinical institution and have research experience.

5. Can rheumatology trainees apply?

Rheumatologists in training can participate in research teams but cannot act as the main applicant.

6. What type of research is supported?

The programme supports research on clinical, epidemiological, healthcare, and biological factors influencing patient trajectories from symptoms to long-term outcomes.

7. Why are patient trajectories important?

Studying patient trajectories helps identify healthcare gaps, improve diagnosis and treatment pathways, and develop better healthcare systems.

Conclusion

The King Baudouin Foundation’s Collaborative Research on Patient Trajectories in Rheumatic and Musculoskeletal Diseases provides an opportunity to advance knowledge about how patients experience healthcare pathways in Belgium. By supporting evidence-based research, the initiative aims to improve diagnosis, treatment, long-term management, and healthcare policies for people living with rheumatic and musculoskeletal diseases.